Providence Capital Advisors, LLC Zoetis Inc. Transaction History

Providence Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $2,358 - $3,042	-13 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $2,517 - $3,211	13 New	13 $3,000
Q1 2020 May 12, 2020	SELL	$92.66 - $144.94 $1,111 - $1,739	-12 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$116.25 - $133.25 $1,395 - $1,599	12 New	12 $2,000
Q2 2019 Aug 13, 2019	SELL	$97.98 - $114.28 $2,449 - $2,857	-25 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$81.56 - $100.67 $2,039 - $2,516	25 New	25 $3,000
Q4 2018 Feb 01, 2019	SELL	$79.28 - $95.27 $17,045 - $20,483	-215 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$63.24 - $72.8 $13,596 - $15,652	215	215 $15,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Capital Advisors, LLC with notifications on news.